Hint? reason why the RS was triggered?
I think James gave a hint. The webcast was Aug 17th. Within that webcast is a treasure trove of information.
Bring forward Aristotle as an LDT (Laboratory Developed Test) they need to do the Cap and CLIA certification and that will take less than two months.That’s @ 30:30 of the webcast! StageZero operates a CAP and CLIA certified lab!
So if it takes less that two months I think it would be realsitic to say that within the next few weeks we will get a NEW RELEASE on that!
Is this the reason to initiate that RS split? OCT 17th is approx two months. Thats if to say when the webcast was dilevered testing started. It could be before or after as well. Do not really know.
Other nice quotes...
“Simultaneous screening of 10 cancers!”
“develop genderspecific cancer detection panels”
“Furthermore, the Company is planning to capitalize on the flexibility
of its SentinelPrinciple® technology platform and expand the applications
of Aristotle™ beyond oncology to help in the diagnosis of disease states
in gastroenterology, neurology, cardiology, autoimmune disease,
heart disease, and psychiatric disorders.”
“According to StageZero, Aristotle™, as potentially the first multiple,
discrete cancer diagnostic test from a single sample of blood, could
realize a $2 billion revenue opportunity.”
“Saliva Collection will continue to stay abreast of this situation (@ 7min of webcast)
Will always introduce new testing as appropriate”
https://www.webcaster4.com/Webcast/Page/2082/36633
https://www.cap.org/laboratory-improvement/accreditation/laboratory-accreditation-program
Do your own DD. Not investment advice at all.